Nuveen LLC Makes New Investment in Phibro Animal Health Corporation $PAHC

Key Points

• Nuveen LLC made a new investment in Phibro Animal Health Corporation, acquiring 482,773 shares valued at approximately $10.3 million, representing a 1.19% ownership stake.
• Analysts have upgraded Phibro Animal Health's stock ratings, with JPMorgan Chase increasing its target price from $25.00 to $35.00, indicating growing confidence in the company's prospects.
• The company recently announced a quarterly dividend of $0.12 per share, with a yield of 1.5%, reflecting its commitment to returning value to shareholders.

Nuveen LLC bought a new stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 482,773 shares of the company's stock, valued at approximately $10,312,000. Nuveen LLC owned about 1.19% of Phibro Animal Health at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at $29,000. National Bank of Canada FI acquired a new position in shares of Phibro Animal Health during the first quarter valued at $30,000. Lazard Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after acquiring an additional 1,589 shares during the period. Virtus Fund Advisers LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at $69,000. Finally, Aquatic Capital Management LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at $69,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Price Performance

Phibro Animal Health stock traded down $0.52 during midday trading on Monday, hitting $31.94. The company's stock had a trading volume of 205,444 shares, compared to its average volume of 251,688. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The stock's 50-day moving average price is $28.45 and its 200-day moving average price is $24.18. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $32.95. The company has a market capitalization of $1.29 billion, a PE ratio of 40.95, a price-to-earnings-growth ratio of 0.54 and a beta of 0.80.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be given a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.5%. Phibro Animal Health's payout ratio is 61.54%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on PAHC shares. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Finally, BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a report on Monday, June 16th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Reduce" and an average price target of $24.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.